Sei Investments CO Galapagos Nv Transaction History

Sei Investments CO

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$96.85 - $148.25 $177,719 - $272,038	-1,835 Closed	0 $0
Q3 2020 Dec 04, 2020	SELL	$122.47 - $213.56 $1,837 - $3,203	-15 Reduced 0.81%	1,835 $260,000
Q3 2020 Nov 06, 2020	SELL	$122.47 - $213.56 $296,009 - $516,174	-2,417 Reduced 56.64%	1,850 $262,000
Q2 2020 Aug 17, 2020	SELL	$185.52 - $231.25 $889,382 - $1.11 Million	-4,794 Reduced 52.91%	4,267 $842,000
Q2 2020 Aug 11, 2020	BUY	$185.52 - $231.25 $376,605 - $469,437	2,030 Added 28.87%	9,061 $1.87 Million
Q1 2020 May 14, 2020	SELL	$143.0 - $274.03 $285,142 - $546,415	-1,994 Reduced 22.09%	7,031 $1.38 Million
Q4 2019 Feb 06, 2020	BUY	$146.12 - $215.82 $346,450 - $511,709	2,371 Added 35.63%	9,025 $1.87 Million
Q3 2019 Nov 12, 2019	SELL	$130.44 - $187.64 $766,726 - $1.1 Million	-5,878 Reduced 46.9%	6,654 $1.02 Million
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $197,600 - $228,592	1,773 Added 16.48%	12,532 $1.62 Million
Q1 2019 May 15, 2019	BUY	$89.61 - $117.78 $961,604 - $1.26 Million	10,731 Added 38325.0%	10,759 $1.27 Million
Q3 2018 Nov 08, 2018	BUY	$90.63 - $120.22 $2,537 - $3,366	28 New	28 $3,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.